Reduction in hospitalization costs, morbidity, disability, and mortality in patients with AIDS ]treated with protease inhibitors

Archives of Medical Research

Volumn 31, Issue 5, 2000, Pages 515-519

  Lavalle, C ^a   Aguilar, J C D ^a   Pena, F ^a   Estrada Aguilar, J L ^a   Avina Zubieta, J A ^a   Madrazo, M ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

CD4+; Costs; HIV AIDS; Protease inhibitors; Viral load

Indexed keywords

CD4 ANTIGEN; PROTEINASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; DISABILITY; FEMALE; FLOW CYTOMETRY; HOSPITALIZATION; HUMAN; MALE; MEXICO; MORBIDITY; MORTALITY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; DISABLED PERSONS; FEMALE; HEALTH CARE COSTS; HIV PROTEASE INHIBITORS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PATIENT ADMISSION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0034633091     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(00)00097-7     Document Type: Article

References (9)

1. The care of HIV-infected adults in the United States
2. The provision and financing of medical care for AIDS patients in US public and private teaching hospitals
3. Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs
4. Medical care cost of AIDS in Massachusetts
5. Specific considerations for cost-effectiveness studies in AIDS
6. Los costos directos del tratamiento del SIDA en México
7. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
8. Decline in deaths from AIDS due to new antiretrovirals